Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Case Rep Intern Med ; 7(12): 002088, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33313019

RESUMEN

We present a case of Takotsubo (stress-induced) cardiomyopathy (TCM) in a healthcare worker that occurred during the COVID-19 pandemic. TCM, or broken-heart syndrome, has various presentations. This case sheds light on how stress due to the COVID-19 pandemic may cause cardiac illness in healthcare workers. LEARNING POINTS: The various symptoms indicating Takotsubo cardiomyopathy are characterized and defined.Physicians should be aware that stress in healthcare workers may cause heart disease.

5.
Exp Physiol ; 93(8): 982-93, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18487314

RESUMEN

Hormonal replacement therapy (HRT) has recently been shown to increase the risk of cardiovascular events in women. However, it is not clear whether the adverse effect of HRT is related to dosage and/or the presence of progestin. Using a mouse model of myocardial infarction (MI), we studied the dose-effect of oestrogen replacement on mortality and cardiac remodelling and dysfunction post-MI in the absence of progestin. Six-week-old females were subjected to ovariectomy (OVX). A pellet containing a low, moderate or high dose of 17beta-oestradiol (E(2); 0.42, 4.2 or 18.8 microg day(-1)) or placebo was implanted subcutaneously on the day of OVX. Myocardial infarction was induced 8 weeks later, and cardiac morphology and function were evaluated 8 weeks after MI. We found that E(2) at moderate and high doses adversely affected mortality. A low dose of E(2) that restored plasma oestrogen close to physiological levels had no significant effect on mortality but tended to improve cardiac function and remodelling, associated with reduced fibrosis and increased capillary density. At the moderate dose, E(2) exacerbated cardiac fibrosis, hypertrophy, dysfunction and dilatation, associated with liver and kidney enlargement and ascites. Protein kinase C and extracellular signal-regulated kinase were increased by MI but were not affected by E(2). In summary, E(2) at a low dose tended to be cardioprotective. At increased doses that raised plasma oestrogen far beyond the physiological level, E(2) was detrimental to the heart. Our data suggest that dosage should be an important consideration when studying the effect of oestrogen replacement on the heart.


Asunto(s)
Terapia de Reemplazo de Estrógeno , Estrógenos/farmacología , Corazón/efectos de los fármacos , Infarto del Miocardio/metabolismo , Infarto del Miocardio/patología , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Estrógenos/sangre , Femenino , Ratones , Ratones Endogámicos C57BL , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Infarto del Miocardio/mortalidad , Miocardio/metabolismo , Miocardio/patología , Ovariectomía , Proteína Quinasa C/metabolismo , Testosterona/sangre
6.
Gend Med ; 4(3): 230-47, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18022590

RESUMEN

BACKGROUND: It is well established that premenopausal women are protected from cardiovascular disease. This gender difference in favor of females is also demonstrated in animal studies. Our research group previously found that female mice had much lower incidence of cardiac rupture and mortality than did males during the acute phase of myocardial infarction (MI); however, the mechanisms responsible for such protection are not fully understood. OBJECTIVE: The aim of this study was to determine whether the favorable cardiac effect observed in female mice with MI is due to an augmented healing process that includes less inflammation, reduced matrix degradation, and enhanced neovascularization. METHODS: Twelve-week-old male and female C57BL/6J mice were subjected to MI by ligating the left anterior descending coronary artery and then euthanized at 1, 4, 7, or 14 days post-MI. Inflammatory cell infiltration and myofibroblast transformation, matrix metalloproteinase (MMP)-2 and MMP-9 activity, tissue inhibitor of metalloproteinase (TIMP)-I expression, and neovascularization were examined by immunohistochemistry, zymography, Western blot, and laser scanning confocal microscopy, respectively. Cardiac function was evaluated by echocardiography on day 14. RESULTS: We found that: (1) neutrophil infiltration during the early phase of MI (1-4 days) was much lower in females than in males and was associated with lower MMP-9 activity and higher TIMP-1 protein expression, indicating less-exaggerated inflammation and extracellular matrix degradation in females; (2) myofibroblast transformation, as indicated by expression of alpha-smooth muscle actin, was significantly greater in females than in males at day 7 of MI (P<0.05), indicating facilitated collagen deposition and scar formation; and (3) neovascularization (vascular area in the infarct border) was markedly increased in females, and was associated with better preserved cardiac function and less left ventricular dilatation. CONCLUSION: Our data suggest that less-exaggerated early inflammation and augmented reparative fibrotic response, indicated by enhanced myofibroblast transformation, may contribute greatly to low rupture rates in females during the acute and subacute phases of MI, whereas enhanced neovascularization may lead to better preserved cardiac function post-MI.


Asunto(s)
Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Infarto del Miocardio/fisiopatología , Infiltración Neutrófila , Recuperación de la Función , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Animales , Western Blotting/métodos , Ecocardiografía , Femenino , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Neovascularización Patológica , Factores Sexuales , Remodelación Ventricular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA